Tag Archives: OMER

H.C. Wainwright Keeps a Buy Rating on Omeros Corp (OMER)

H.C. Wainwright analyst Ram Selvaraju reiterated a Buy rating on Omeros Corp (OMER – Research Report) today and set a price target of $34. The company’s shares closed yesterday at $14.68. According to TipRanks.com, Selvaraju ‘s ranking currently consits of

H.C. Wainwright Reiterates a Buy Rating on Omeros Corp (OMER)

H.C. Wainwright analyst Ram Selvaraju reiterated a Buy rating on Omeros Corp (OMER – Research Report) today and set a price target of $34. The company’s shares closed yesterday at $12.94. Selvaraju said: “Valuation methodology, risks and uncertainties. We currently

H.C. Wainwright Remains a Buy on Omeros Corp (OMER)

H.C. Wainwright analyst Ram Selvaraju reiterated a Buy rating on Omeros Corp (OMER – Research Report) today and set a price target of $34. The company’s shares closed yesterday at $14.35. Selvaraju noted: “Valuation methodology, risks and uncertainties. We currently

H.C. Wainwright Sticks to Their Buy Rating for Omeros Corp (OMER)

H.C. Wainwright analyst Ram Selvaraju reiterated a Buy rating on Omeros Corp (OMER – Research Report) today and set a price target of $34. The company’s shares closed yesterday at $14.04. Selvaraju said: “Valuation methodology, risks and uncertainties. We currently

Omeros Corp (OMER) Receives a Buy from Maxim Group

Maxim Group analyst Jason McCarthy maintained a Buy rating on Omeros Corp (OMER – Research Report) today and set a price target of $32. The company’s shares opened today at $14.01. McCarthy observed: “Omeros reported 3Q18 with $4.6M in Omidria

Tuesday’s Midday Movers: Tokai Pharma (TKAI), Titan Pharmaceuticals (TTNP), Amarin (AMRN), Dynavax (DVAX), Omeros Corp (OMER)

So far Tuesday, October 23, NASDAQ is up 1.95% and the S&P is up 1.35%. Here are this morning’s most active stocks: Tokai Pharma (NASDAQ:TKAI), Titan Pharmaceuticals (NASDAQ:TTNP), Amarin (NASDAQ:AMRN), Dynavax (NASDAQ:DVAX) and Omeros Corp (NASDAQ:OMER). Tokai Pharma is down